Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer
Crossref DOI link: https://doi.org/10.1186/s12957-015-0455-3
Published Online: 2015-02-15
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peng, Xingang
Wang, Peige
Li, Shikuan
Zhang, Guangyong
Hu, Sanyuan
License valid from 2015-02-15
Article History
Received: 29 July 2014
Accepted: 8 January 2015
First Online: 15 February 2015